🔎 Trials Near Me

Home › Acute Biphenotypic Leukemia › Minnesota › Minneapolis

Pag-aaral pangklinika para sa Acute Biphenotypic Leukemia sa Minneapolis, MN

Isang pag-aaral para sa Acute Biphenotypic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Minneapolis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Nagre-recruitPhase 3
  • Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
  • University of Minnesota/Masonic Cancer Center, Minneapolis
365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Nagre-recruitPhase 1/2
  • Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
  • University of Minnesota/Masonic Cancer Center, Minneapolis
Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

Allo HSCT Using RIC and PTCy for Hematological Diseases

Nagre-recruitPhase 2
  • Masonic Cancer Center at University of Minnesota, Minneapolis
Hanggang edad 75 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT05805605

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1
  • Children's Hospital and Clinics of Minnesota, Minneapolis
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa Acute Biphenotypic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Minneapolis

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.